Anticoccidial Drugs Market is Expected to Gains Significantly from Increasing Number of Animal Adopters Worldwide: Fortune Business Insights

Global Anticoccidial Drugs Market to Grow Exponentially Owing to Increasing Prevalence of Zootonic Diseases

The global Anticoccidial drugs market is prognosticated to witness high growth on account of the rising awareness about animal health., says Fortune Business Insights in their new report. Creative Diagnostics, a company operating in the same market recently developed Anticoccidial drug analysis products for testing residues for this drug in animals in April 2019. Such innovations are likely to bode well for the global market in the long run. The increasing awareness about zootonic diseases is a major factor boosting the market.

The global anticoccidial drug market is categorized on the basis of drug class, animal type, distribution channel, and geography. Among these drugs class segment is further classified into Amprolium, Sulphonamides, antibiotic, Ionophores, and others. Based on animal type, the market is segmented into companion animal and livestock, wherein further segmentation of livestock animal includes poultry, cattle, and others. With respect to distribution channel, the market is divided into online pharmacy, retail pharmacy, and veterinary hospitals. According to the current scenario, the livestock animal type segment is expected to hold a major share in the market. This is because of the rise in disease outbreak and increasing awareness about coccidian diseases among poultry owners.

As per the report, the market highlights some of the major shareholders in the global anticoccidial drugs market. These companies are mentioned below:

  • Virbac
  • Boehringer Ingelheim International GmbH
  • Virbac S.A
  • Bayer AG
  • Elanco
  • Novartis AG
  • Zoetis

More Trending Topics From Fortune Business [email protected]

Ultrasonic Dissection Devices Market to Expand Steadily as Incidence of Chronic Diseases Rises: Fortune Business Insights

Diabetic Neuropathy Market to Witness Growth Due to Increasing Cases of Obesity and Cardiovascular Diseases Reported Worldwide, says Fortune Business Insights

About Us

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *